aHUS is suspected in patients with TMA after ruling out secondary causes, i.e. ADAMTS13 activity is above 10% ruling out TTP and tests for STEC-HUS are negative (grade 1B). The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.